Skip to main content
Defective K-Ras oncoproteins overcome impaired effector activation to initiate leukemia in vivo.
Targeting oncogenic Ras signaling in hematologic malignancies.
Impact of immune modulation with in vivo T-cell depletion and myleoablative total body irradiation conditioning on outcomes after unrelated donor transplantation for childhood acute lymphoblastic leukemia.
Advancing the STATus of MPN pathogenesis.
Silent cerebral infarcts: a review on a prevalent and progressive cause of neurologic injury in sickle cell anemia.
Chelation use and iron burden in North American and British thalassemia patients: a report from the Thalassemia Longitudinal Cohort.
A phase 2 study of the safety, tolerability, and pharmacodynamics of FBS0701, a novel oral iron chelator, in transfusional iron overload.
Inhibiting the palmitoylation/depalmitoylation cycle selectively reduces the growth of hematopoietic cells expressing oncogenic Nras.
IL-21 is the primary common ? chain-binding cytokine required for human B-cell differentiation in vivo.